CPD Activities
Showing 6,431-6,435 of 12,613 items.
| # | Activity Title | CPD Provider | Start Date | Event Time | Location | Cost (UGX) | CPD Points | End Date | Status | Details |
|---|---|---|---|---|---|---|---|---|---|---|
| 6431 | Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice | INFECTIOUS DISEASES INSTITUTE | Jul 23, 2024 | 11:00 AM | Hybrid | 0 | 1 | Jul 23, 2024 | Closed | Read More |
| 6432 | Switch Meeting | INFECTIOUS DISEASES INSTITUTE | Jul 23, 2024 | 10:30 AM | Hybrid | 0 | 1 | Jul 23, 2024 | Closed | Read More |
| 6433 | PCT GSM | INFECTIOUS DISEASES INSTITUTE | Jul 23, 2024 | 10:30 AM | Training Room 2&3 | 0 | 2 | Jul 23, 2024 | Closed | Read More |
| 6434 | Switch Meeting | INFECTIOUS DISEASES INSTITUTE | Jul 23, 2024 | 09:00 AM | Hybrid | 0 | 1 | Jul 23, 2024 | Closed | Read More |
| 6435 | Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial | INFECTIOUS DISEASES INSTITUTE | Jul 22, 2024 | 09:00 AM | zoom | 0 | 1 | Jul 22, 2024 | Closed | Read More |